T Cell Dysfunction and Exhaustion in Cancer

Zhang, Zhen, Liu, Shasha, Zhang, Bin, Qiao, Liang, Zhang, Yi, Zhang, Yi·2020·Frontiers in Cell and Developmental Biology

Cited by (386)

Items 201–300 of 386

  1. Drug Repurposing in Oncology, an Attractive Opportunity for Novel Combinatorial Regimens
    Paolo Falvo, Stefania Orecchioni, Stefania Roma, Alessandro Raveane, Francesco Bertolini · 2020 · Current Medicinal Chemistry
  2. Modulating the proliferative and cytotoxic properties of patient-derived TIL by a synthetic immune niche of immobilized CCL21 and ICAM1
    Sharon Yunger, Benjamin Geiger, Nir Friedman, Michal Judith Besser, Shimrit Adutler‐Lieber · 2023 · Frontiers in Oncology
  3. ID1 and ID3 functions in the modulation of the tumour immune microenvironment in adult patients with B-cell acute lymphoblastic leukaemia
    Nathaly Poveda-Garavito, Carlos A. Orozco, X. Torres, Nataly Cruz‐Rodriguez, Rafael Santiago Parra-Medina, Sandra Quijano, Jovanny Zabaleta, Alba Lucía Cómbita · 2024 · Frontiers in Immunology
  4. A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming
    Mina Afrashteh Nour, Mansour Rajabivahid, Marjan Sadat Seyed Mehdi, Safa Tahmasebi, Sepideh Nasirzadeh Dashtgol, Mahmoud Dehghani-Ghorbi, Ahmad Ghorbani Vanan, Farid Ghorbaninezhad · 2025 · Cancer Cell International
  5. GK-1 effectively reduces angiogenesis and prevents T cell exhaustion in a breast cancer murine experimental model
    Juan Alberto Hernández-Aceves, Jacquelynne Brenda Cervantes‐Torres, Diana Torres‐García, Francisco J Zuñiga-Flores, Osiris J Patiño-Chávez, Jorge Armando Pena Agudelo, José Eduardo Aguayo-Flores, Yonathan Garfias, Laura Montero, Laura Romero-Romero et al. · 2023 · Cancer Immunology Immunotherapy
  6. IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
    Nicholas R. Hum, Aimy Sebastian, Kelly A. Martin, Naiomy Deliz Rios‐Arce, Sean F. Gilmore, David M. Gravano, Elizabeth K. Wheeler, Matthew A. Coleman, Gabriela G. Loots · 2022 · Frontiers in Oncology
  7. mRNA—From COVID-19 Treatment to Cancer Immunotherapy
    W. Kŕause · 2023 · Biomedicines
  8. Caspase activation in tumour‐infiltrating lymphocytes is associated with lymph node metastasis in oral squamous cell carcinoma
    Priyanka G. Bhosale, Robert A Kennedy, Fiona M. Watt · 2023 · The Journal of Pathology
  9. The Association Between Albumin Levels and Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
    Deniz Can Güven, Taha Koray Şahin, Enes Erul, Alessandro Rizzo, Angela Dalia Ricci, Şuayib Yalçın · 2022 · Research Square
  10. Association of tuberculosis risk with genetic polymorphisms of the immune checkpoint genes PDCD1, CTLA-4, and TIM3
    Chi‐Wei Liu, Lawrence Shih-Hsin Wu, Chou-Jui Lin, Hsing-Chu Wu, Kuei-Chi Liu, Shih‐Wei Lee · 2024 · PLoS ONE
  11. Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodies
    Edo Kapetanovic, Cédric R. Weber, Marine Bruand, Daniel Pöschl, Jakub Kucharczyk, Elisabeth Hirth, Claudius L. Dietsche, Riyaz Ahmed Khan, Bastian Wagner, Olivier Belli et al. · 2024 · Nature Biomedical Engineering
  12. Pharmacological strategies to overcome immune checkpoint inhibitor resistance in non-small cell lung cancer
    Yuyu Xu, Huiling Shen, Dong Shang, Cailin Zhu · 2026 · Frontiers in Oncology
  13. The transcription factor TOX is involved in the regulation of T-cell exhaustion in neuroblastoma
    Mengmiao Pei, Wenjia Chai, Xiaolin Wang, Yanlong Duan, Hui Wang, Yue Xi, Wenjun Mou, Wei Wang, Xi Chen, Hui Zhang et al. · 2022 · Immunology Letters
  14. Promises and challenges for targeting the immunological players in the tumor micro-environment – Critical determinants for NP-based therapy
    P.K. Suresh, Arindam Banerjee, Preeti Singh · 2023 · OpenNano
  15. The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy
    Sylvia Annabel Dass, Rehasri Selva Rajan, Gee Jun Tye, Venugopal Balakrishnan · 2021 · Human Vaccines & Immunotherapeutics
  16. Reviving human γδT cells from apoptosis induced by IL-12/18 via p-JNK inhibition
    Yuan Song, Huey Yee Teo, Yonghao Liu, Xiaomeng Zhang, Jinmiao Chen, Yongliang Zhang, Haiyan Liu · 2022 · Journal of Leukocyte Biology
  17. Inducing Immunogenic Cancer Cell Death through Oxygen‐Economized Photodynamic Therapy with Nitric Oxide‐Releasing Photosensitizers
    Feijie Xu, Meijun Wang, Eunice Dotse, Kwan Ting Chow, Pui‐Chi Lo · 2024 · Angewandte Chemie
  18. The intratumoral landscape of T cell receptor repertoire in esophageal squamous cell carcinoma
    Meng Yang, Dan He, Yu Sun, Yunquan Guo, Yu Ma, Lin Feng, Meng Liu · 2024 · Journal of Translational Medicine
  19. T cell exhaustion in pediatric B-ALL: current knowledge and future perspectives
    Tanmaya Atre, Gregor S. D. Reid · 2025 · Frontiers in Immunology
  20. Ordinary differential equation model of cancer-associated fibroblast heterogeneity predicts treatment outcomes
    Jun-Ho Lee, Eunjung Kim · 2025 · npj Systems Biology and Applications
  21. Plasma exosomes from individuals with type 2 diabetes drive breast cancer aggression in patient-derived organoids
    Christina S. Ennis, Michael Seen, Andrew Chen, Heejoo Kang, Adrian Ilinski, Kiana Mahdaviani, Naomi Yu Ko, Stefano Monti, Gerald V. Denis · 2025 · Communications Biology
  22. Drug-loaded bispecific T cell nanoengager overcomes T cell exhaustion for potent cancer immunotherapy
    Jinjin Wang, Xisha Huang, Qiangqiang Shi, Kelsey L. Swingle, Alex G. Hamilton, Ningqiang Gong, Michael J. Mitchell · 2025 · Proceedings of the National Academy of Sciences
  23. Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer
    Janna Berg, Ann Rita Halvorsen, May‐Bente Bengtson, Morten Lindberg, Bente Lise Halvorsen, Pål Aukrust, Åslaug Helland, Thor Ueland · 2022 · Frontiers in Immunology
  24. Fluorogenic Granzyme A Substrates Enable Real‐Time Imaging of Adaptive Immune Cell Activity
    Zhiming Cheng, Emily J Thompson, Lorena Mendive‐Tapia, Jamie I. Scott, Sam Benson, Takanori Kitamura, Ana Senan‐Salinas, Youhani Samarakoon, Edward W. Roberts, Maykel A. Arias et al. · 2022 · Angewandte Chemie
  25. Targeting BTLA with the peptide inhibitor HVEM(14-39) – A new way to restore the activity of T cells in melanoma
    Karolina Wojciechowicz, Katarzyna Kuncewicz, Jacek Rutkowski, Jacek Jassem, Sylwia Rodziewicz‐Motowidło, Anna Wardowska, Marta Spodzieja · 2024 · Biomedicine & Pharmacotherapy
  26. A comprehensive pan-cancer analysis revealing the role of ITPRIPL1 as a prognostic and immunological biomarker
    Wenyuan Duan, Wenhao Tian, Zhongyi Li, Yunsong Liu, Linping Xu · 2024 · Frontiers in Molecular Biosciences
  27. Intratumoral PD1+CD38+Tim3+ CD8+ T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer
    Debashree Basak, Soumya Mondal, Swadeep Kumar Srivastava, Deborpita Sarkar, Ishita Sarkar, Sukanya Basu, Arpita Bhoumik, Snehanshu Chowdhury, Dilip Kumar Pal, Shilpak Chatterjee · 2023 · Cells
  28. C-5401331 identified as a novel T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) inhibitor to control acute myeloid leukemia (AML) cell proliferation
    Mesfer Mohammad Al Shahrani, Reem M. Gahtani, Mohammed Makkawi · 2024 · Medical Oncology
  29. Global pannexin 1 deletion increases tumor‐infiltrating lymphocytes in the BRAF /Pten mouse melanoma model
    Rafael E. Sanchez‐Pupo, Garth A. Finch, Danielle E. Johnston, Heather C. Craig, Rober Abdo, Kevin Barr, Steven M. Kerfoot, Lina Dagnino, Silvia Peñuela · 2024 · Molecular Oncology
  30. CD4+ Memory Stem T Cell in Peripheral Blood: A Promising Immune Index for Early Screening and Auxiliary Diagnosis of Colorectal Cancer
    Yan Lu, Qiaohong Zhang, Longyi Zhang · 2021 · Frontiers in Oncology
  31. Targeting cancer-associated glycans as a therapeutic strategy in leukemia
    Ashraf Abdullah Saad · 2022 · All Life
  32. Emerging frontiers in adoptive cell therapies: innovations, challenges, and future perspectives
    Anmol Dogra, Ranjeet Kumar Yadav, Himanshu Singh, Vimal Datt · 2025 · Medical Oncology
  33. The Unseen Enemies: Harnessing the Role of Neutrophil Extracellular Traps in Breast Cancer Progression, Immune Evasion, and Treatment Resistance
    Somayeh Moradpanah, Shabnam Forouzin, Fatemeh Samadi Nasab, Shahrzad Amirlatifi, Parichehr Shirkosh, Seyed Mehdi Marashi, Nastaran Khodakarim · 2025 · Clinical Breast Cancer
  34. Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial
    Caron Alyce Jacobson, Jason R. Westin, David Bernard Miklos, Alex Francisco Herrera, Jerome Ritz, Scott J. Rodig, Yohei Arihara, Subing Cao, Jennifer Sun, Daqin Mao et al. · 2025 · Clinical Cancer Research
  35. Epigenetic editing to advance CAR T cell therapy
    Laura Horvathova, Marianne G. Rots, Valerie R. Wiersma · 2026 · Clinical Epigenetics
  36. Roles of hypoxia in tumor progression and novel strategies for cancer treatment
    Bui Dinh Khan, Tran Ngo The Nhan, Hoang Nguyen Minh Chau, Nguyen Thi Yen Nhi · 2022 · Biomedical Research and Therapy
  37. Engineering strategies to optimise adoptive cell therapy in ovarian cancer
    Catarina Guerra, Milena Kalaitsidou, Gray Kueberuwa, Robert E. Hawkins, Richard John Edmondson · 2023 · Cancer Treatment Reviews
  38. Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
    Davide Ramoni, Simona Coco, Giovanni Rossi, Chiara Dellepiane, Elisa Bennicelli, Sara Santamaria, Linda Zinoli, Alberto Stefano Tagliafico, Marco Tagliamento, Giulia Barletta et al. · 2024 · Lung
  39. Evaluation of piggyBac‐mediated anti‐CD19 CAR‐T cells after ex vivo expansion with aAPCs or magnetic beads
    Li‐Rong Yang, Lin Li, Mingyao Meng, Wen‐Ju Wang, Songlin Yang, Yiyi Zhao, Run‐Qing Wang, Hui Gao, Weiwei Tang, Yang Yang et al. · 2020 · Journal of Cellular and Molecular Medicine
  40. Particle elasticity influences polymeric artificial antigen presenting cell effectiveness in vivo via CD8+ T cell activation, macrophage uptake, and the protein corona
    Savannah E. Est-Witte, Sydney R. Shannon, Dennis H. Gong, Kaitlyn G. Calabresi, Jawaun J. Harris, Kaitlyn Storm, Edwin Yoo, Ariel Isser, Vivek Jani, Natalie K. Livingston et al. · 2024 · Nano Research
  41. Strategies for Overcoming Disparities for Patients With Hematologic Malignancies and for Improving Enrollment on Clinical Trials
    STEPHANIE F. WILLIAMS, Amy A. Ayers, Michelle A.T. Hildebrandt, Lorna Haughton. McNeill, Christopher R. Flowers · 2020 · ONCOLOGY
  42. Biomaterial nanocarrier-driven mechanisms to modulate anti-tumor immunity
    Luman Liu, Michael J. Wannemuehler, Balaji Narasimhan · 2021 · Current Opinion in Biomedical Engineering
  43. Non-small cell lung cancer in the era of immunotherapy
    Quillan Huang, Jan Ole Kemnade, Loraine Cornwell, Farrah Kheradmand, Anita Lyn Sabichi, Devika Govind Das · 2022 · Seminars in Oncology
  44. Decisional Capacity Determination in Patients With Cancer
    Daniel Curtis McFarland, Liz Blackler, Fay J. Hlubocky, Rebecca M. Saracino, James N. Masciale, Martin Chin, Yesne Alici, Louis P. Voigt · 2020 · ONCOLOGY
  45. C chemokines are prognostic biomarkers correlated with diverse immune cell infiltrations in clear cell renal cell carcinoma
    Zhiguo Chen, Ruoyu Wu, Junjie Ma, Junhua Zheng · 2022 · Translational Cancer Research
  46. S100A9 enhances tumor immune suppression and cancer cell survival in small cell lung cancer
    Manish Charan, Sanjay R. Mishra, Konstantin Shilo, Xiaoli Zhang, Ajeet Kumar Verma, Pratyusha Ghanta, Amy Webb, Ramesh Kumar Ganju · 2025 · Cell Death and Disease
  47. Differential RNA expression of immune-related genes and tumor cell proximity from intratumoral M1 macrophages in acral lentiginous melanomas treated with PD-1 blockade
    Seoree Kim, Joo Ri Kim, Ji Hyun Lee, Suk-Ho Moon, Su In Jo, Dong‐Jun Bae, Minwoo Park, Sunyoung Lee, Jeong-Oh Kim, Cookjin Lee et al. · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  48. Modeling the Development of Cellular Exhaustion and Tumor-Immune Stalemate
    Tyler Simmons, Doron Levy · 2023 · Bulletin of Mathematical Biology
  49. CAR-T-cell therapy in meningioma: current investigations, advancements and insight into future directions
    Shree Rath, Murtaja Satea Shafeea, Abbas F. Abdul Hussein, Ahmed Shamil Hashim, Sara Hassanaien, Santiago Pastrana-Brandes, Bipin Kumar Chaurasia · 2024 · Annals of Medicine and Surgery
  50. Immune Cluster and PPI Network Analyses Identified CXCR3 as a Key Node of Immunoregulation in Head and Neck Cancer
    Ping Wang, Yanli Wang, Yuanjun Jiang, Minghong Li, Guang Li, Qiao Qiao · 2021 · Frontiers in Oncology
  51. Inhibition of interferon regulatory factor 4 orchestrates T cell dysfunction, extending mouse cardiac allograft survival
    Wenjia Yuan, Hedong Zhang, Longkai Peng, Chao Chen, Feng Chen, Zhouqi Tang, Pengcheng Cui, Yaguang Li, Tengfang Li, Xia Qiu et al. · 2024 · Chinese Medical Journal
  52. Response to immune checkpoint inhibitor rechallenge after high-grade immune related adverse events in patients with advanced melanoma
    Payal C. Shah, Salman Rafi Punekar, Anna C. Pavlick · 2021 · Melanoma Research
  53. Sialic acid-functionalized nanomaterials for targeted cancer therapy, diagnosis, and theranostics
    Abulfazl Vatankhah, Sepehr Hoseinzadeh Moghaddam, Fatemeh Oroojalian, Prashant Kesharwani, Amirhossein Sahebkar · 2025 · International Journal of Pharmaceutics
  54. Personalizing DNA Cancer Vaccines
    Annie A. Wu, Kaiqi Peng, Melanie Vukovich, Michelle Zhu, Yuki Lin, Amrita Bagga, T.‐C. Wu, Chien‐Fu Hung · 2025 · Journal of Personalized Medicine
  55. Correlation of immune cell subsets in the tumor microenvironment and peripheral blood with immunotherapy response in esophageal squamous cell carcinoma
    Wei Chen, Lian Gong, Yahu Li, Mengyao Wu, Min Tao · 2025 · Frontiers in Immunology
  56. Dynamic PD-L1 Regulation Shapes Tumor Immune Escape and Response to Immunotherapy
    Bruce Pell, Aigerim Kalizhanova, Aisha Tursynkozha, Denise Dengi, Ardak Kashkynbayev, Yang Kuang · 2025 · Cancers
  57. CD93-targeted resveratrol-loaded PLGA nanoparticles remodel CD8⁺ T cell metabolism through AIF-mediated oxidative phosphorylation to overcome lung cancer immunotherapy resistance
    Zhou Jiang, Yuning Li · 2026 · Journal of Nanobiotechnology
  58. Interplay between CD28 and PD-1 in T cell immunotherapy
    Zuhayr Jafri, Jingwen Zhang, Connor H. O’Meara, Anthony Michael Joshua, Christopher Richard Parish, Levon Michael Khachigian · 2024 · Vascular Pharmacology
  59. Antitumoral effectiveness and safety of intravenous versus subcutaneous administration of immunomodulatory peptide GK-1 in a murine breast cancer model
    Juan Alberto Hernández-Aceves, Jacquelynne Brenda Cervantes‐Torres, Alfredo Cruz‐Gregorio, Ana Karina Aranda‐Rivera, Diego Moctezuma-Rocha, Jorge Armando Pena Agudelo, Osiris J Patiño-Chávez, Marisela Hernández, Sergio Sifontes, Tonathiu Rodríguez et al. · 2025 · Vaccine
  60. Immunotherapy in the complex treatment of tumor diseases
    Victor Ivanovich Seledtsov, Galina Victorovna Seledtsova, Доржиева Аяна Баяровна, Irina P. Ivanova · 2022 · Siberian Journal of Oncology
  61. Practice-oriented solutions integrating intraoperative electron irradiation and personalized proton therapy for recurrent or unresectable cancers: Proof of concept and potential for dual FLASH effect
    Felipe Ángel Calvo, Adriana Ayestarán, Javier Serrano, Mauricio Cambeiro, Jacobo Palma, Rosa M. Meirino, Miguel Ángel Morcillo, Fernando Lapuente, Luis M. Chiva, Borja Aguilar et al. · 2022 · Frontiers in Oncology
  62. Immune Modulatory Profile of the Pateamines PatA and Des-Methyl Des-Amino PatA
    Susanne Schiffmann, Marina Henke, Sophie Brünner, Alexandre Bennett, Yassin Yagubi, F. Magari, Michael John Parnham, Arnold Grünweller · 2024 · International Journal of Molecular Sciences
  63. PIK3R2 immunostaining status predicts prognosis in patients with newly diagnosed glioblastoma treated with an autologous tumor vaccine
    Kazuki Akutagawa, Shunichiro Miki, Erika Yamada, Noriaki Sakamoto, Tsubasa Miyazaki, Narushi Sugii, Alexander Zaboronok, Masahide Matsuda, Eiichi Ishikawa · 2025 · Journal of Neuro-Oncology
  64. Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients
    Soo Hyun Hwang, Maie A. St. John · 2025 · Cancers
  65. Tumor Microenvironment-Driven CD8⁺ T Cell Exhaustion: Mechanisms, Therapeutic Implications, and Strategies for Reinvigoration
    Reza Izadfar, Ali Alishvandi · 2025 · The Cancer Review
  66. Immune checkpoint crosstalk between LAG-3 and CD39/CD73 in glioblastoma: dual-pathway regulation of metabolic exhaustion and therapeutic reversal strategies
    Dr. Arpita Mukherjee · 2026 · Journal of the Egyptian National Cancer Institute
  67. PAX5 haploinsufficiency induced CD8+ T cells dysfunction or exhaustion by high expression of immune inhibitory-related molecules
    Liang Mi, Duanhao Gong, Lei Wang, Xue Liang, Jiao Meng, Wei Huang, Jianfeng Zhou · 2021 · Cancer Treatment and Research Communications
  68. Lymphocyte subsets and soluble forms of MIC-A and MIC-B are prognostic factors in non-Hodgkin lymphoma patients
    Ana Cristina Olivas‐Bejarano, Laura Arcelia Montiel‐Cervantes, Flor Perez-Retiguin, Sócrates Alberto García-Gutiérrez, Teresita Rocío Cruz-Hernández, Ruth Angelica Lezama-Palacios, Elba Reyes‐Maldonado, Jorge Vela‐Ojeda · 2023 · Annals of Hematology
  69. Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma
    Christy Los, Sebastian Klobuch, John B.A.G. Haanen · 2024 · The Cancer Journal
  70. Soluble MIC‐A , IPI , and response to treatment strongly predict survival in patients with germinal center diffuse large B cell lymphoma
    Jorge Vela‐Ojeda, Ana Cristina Olivas‐Bejarano, Laura Arcelia Montiel‐Cervantes, Érika Rosales-Cruz, Sócrates Alberto García-Gutiérrez, Ruth Angelica Lezama-Palacios, Elba Reyes‐Maldonado · 2024 · European Journal Of Haematology
  71. Incidence of Post-therapeutic Malignancies in Benign and Malignant Gastric Diseases, Human Leukocyte Antigen-restricted Human Endogenous Retrovirus Gene-derived Peptides, and Survival
    Kyoji Ogoshi, Kunihiro Iwata, Chikara Kunisaki, Seiichi Takenoshita, K Isono · 2024 · Annals of Cancer Research and Therapy
  72. Visualizing immunotherapy for multiple myeloma worldwide from 2013 to 2023: A bibliometric analysis
    Jinqiao Li, Xiaoxia Li, Yueyue Fu, Hongbin Meng, Dan Xu, Wenyi Hou · 2024 · Human Vaccines & Immunotherapeutics
  73. Exploring neuroblastoma’s cellular microenvironment: A novel approach using cellular automata to model Celyvir treatment
    José García Otero, Juan Belmonte-Beitia, Juan Jiménez-Sánchez · 2025 · Computers in Biology and Medicine
  74. Epigenetic programming of the immune responses in cancer
    Abbey A. Saadey, Amir Yousif, Hazem E. Ghoneim · 2021 · Elsevier eBooks
  75. Induced pluripotent stem cells–derived hematopoietic progenitors for cellular immunotherapies
    Igor I. Slukvin, Saritha Sandra D'Souza, Akhilesh Kumar · 2021 · Elsevier eBooks
  76. Pollock: fishing for cell states
    Erik P. Storrs, Daniel Cui Zhou, Michael C. Wendl, Matthew A. Wyczalkowski, Alla Y. Karpova, Liang-Bo Wang, Yize Li, Austin N. Southard-Smith, Reyka G. Jayasinghe, Lijun Yao et al. · 2022 · Bioinformatics Advances
  77. The Correlation between Peripheral Blood Index and Immune Cell Expansion in Vietnamese Elderly Lung Cancer Patients
    Hoang-Phuong Nguyen, Viet Anh Bui, Ai-Xuan Thi Hoang, Phong Van Nguyen, Dac-Tu Nguyen, Hien Thi, Hai-Anh Le, Thanh-Luan Nguyen, Hoang Thi My Nhung, Nguyễn Thanh Liêm et al. · 2023 · International Journal of Molecular Sciences
  78. Characterization of the adaptive cellular and humoral immune responses to persistent colonization of Brucella abortus strain RB51 in a Jersey cow
    Paola Mercedes Boggiatto, Haley M. Sterle, Shollie M. Falkenberg, Kaitlyn M. Sarlo Davila, Ellie J. Putz, Steven C. Olsen · 2024 · Frontiers in Veterinary Science
  79. The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment
    Vanessa Cristaldi, Lodovico Terzi di Bergamo, Lucrezia Patruno, Marinos Kallikourdis, Giada Andrea Cassanmagnago, Francesco Corrado, Eleonora Calabretta, Adalgisa Condoluci, Martina Di Trani, Daoud Rahal et al. · 2025 · Frontiers in Oncology
  80. Prostate Cancer Vaccines: Progress, Challenges, and Future Directions
    Stefanus Vicky Bernhard Elisa Runtunuwu, Trina Ekawati Tallei, Grace L. A. Turalaki · 2025 · Heca Journal of Applied Sciences
  81. Perfluorohexane Emulsions Induce Macrophage-Stimulating Effects through iNOS Expression
    Ruoqi Gao, Ethan Wang, Victor Pineiro, Lalit Chudal, Julien Santelli, Connor Endsley, Adam Woodward, Caroline de Gracia Lux, Jacques Lux, Robert F. Mattrey · 2025 · ACS Applied Bio Materials
  82. Sex differences, family history of cancer, association with peptides matching the human endogenous retrovirus genes, and survival
    Kyoji Ogoshi, Kunihiro Iwata, Seiichi Takenoshita · 2025 · Annals of Cancer Research and Therapy
  83. Tumor-Draining Lymph Node-Targeted Electrochemotherapy: A Hypothesis for In Situ Cancer Vaccination
    Reihane Mahdavi, Hossein Ataee, Amirparsa Abdollahian Dehkordi, Mahdi Shabani, Azam Hemati, Mohammad Abdolahad · 2025 · Biomedicines
  84. Antioxidant N-Acetylcysteine Facilitates Breast Cancer Metas-Tasis via Immunosuppressive Reprogramming of Neutrophils
    Jin Zhang, Di Wang, Huige Wang, Qiuyu Wu, Menghao Liu, Qing Li, Zheng Gong · 2026 · International Journal of Molecular Sciences
  85. Pre-treatment endocrine–nutritional signatures predict clinical benefit from PD-1/PD-L1 blockade in hematologic malignancies
    Ningjing Huang, Yu Guan · 2026 · Frontiers in Nutrition
  86. Exploring the Potential of Receptor Silencing in the Tumor Microenvironment by RNA Interference
    KARINA MAYUMI TANI BEZERRA DE MELO, Beatriz Mendonça Alves Bandeira, Pedro Vinícius Silva Novis, Micaela Evellin dos Santos Silva, Ingrid Andrêssa de Moura, Antônio Carlos de Freitas, Anna Jéssica Duarte Silva · 2026 · Biomolecules
  87. Low intensity vibration as a novel strategy to normalize age-related deficits in T cell proliferation, activation, and function
    Christopher P. Ashdown, Ankur Sikder, Andreas G. Kaimis, Meilin Ete Chan, Brian S. Sheridan, Clinton T. Rubin · 2026 · Scientific Reports
  88. Reversing T cell dysfunction in a novel in vitro model of T cell exhaustion reveals differential roles of RASA2
    Hilal Saraç, Rachael Nicholson, Rebecca N. Graham, Meera Augustus, R. Taghavi, Dympna J. Connolly, Lindsay Lim, Sofia Da Silva Lourenco · 2026 · Frontiers in Immunology
  89. Radiotherapy as an immunomodulator in cancer: Synergy with immunotherapy and roadmap for optimization
    Chenyi Zhao · 2026 · Journal of Radiation Research and Applied Sciences
  90. Remodeling the Tumor Immune Microenvironment by Traditional Chinese Medicine: Mechanisms Focusing on TAM Polarization and CD8 + T Cell Exhaustion
    Yannan Geng, Yuanjun Qu, Ji Li, X Wang, Changying Ji, Guangze Wang · 2026 · Journal of Biochemical and Molecular Toxicology
  91. Inhibition of colorectal cancer targets IL-6, CTLA-4, & B7-2 by Tislelizumab: molecular docking, dynamics, & STRING protein-protein network analysis
    Mahmoud Elkazzaz, Shahid Ullah, Tianshun Gao, Israa Mohamed Shamkh, Amr Kamel Khalil Ahmed, Ted X. Wu, Maii S. Elsharayidi, Mohammad Shahbaz Khan, Aziz-ur Rehman, Marwa M. Lotfy et al. · 2023 · Informatics in Medicine Unlocked
  92. Survivin‐Based Recombinant Overlapping Peptides Induce T Lymphocyte Cytotoxicity and Prolong the Survival in In Vivo Melanoma Model
    Yuan‐Ting Zhang, Yihan Zhou, Min Gong, Qing Zhang, Qiujie Zheng, Yuanying Shen, Wenshu Lu, Shisong Jiang · 2023 · Advanced Therapeutics
  93. Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer: proof-of-principle
    Jonas Steenbrugge, Glenn Pauwelyn, Kristel Demeyere, Nausikaa Devriendt, H. de Rooster, Niek N. Sanders, Jan H. Spaas, Evelyne Meyer · 2023 · Frontiers in Immunology
  94. The Mechanism of Action of Cancer Therapeutic Vaccines and Their Application Prospects
    Mingrui Li · 2024 · Transactions on Materials Biotechnology and Life Sciences
  95. Effects of reprogrammed splenic CD8+ T-cells in vitro and in mice with spontaneous metastatic Lewis lung carcinoma
    Е. G. Skurikhin, N. Ermakova, М. А. Zhukova, Edgar Sergeevich Pan, Darius Widera, Lubov Alexandrovna Sandrikina, Lena Kogai, О. V. Pershina, A. Pakhomova, V. Yu. Pan et al. · 2024 · BMC Cancer
  96. Implication of T Cell Exhaustion in Neuropsychiatric Disorders: Neuroimmunopathology and Treatment Strategies
    Kiarash Saleki, Nima Rezaei · 2024 · Integrated science
  97. Molecular Biology of Urothelial Carcinoma
    Peir‐In Liang, Ti‐Chun Chan, Yow‐Ling Shiue, Chien‐Feng Li · 2021 · Journal of Cancer Research and Practice
  98. Single-cell Sequencing: The Technological Revolution Behind a New Wave of Multiomic Studies in Basic and Cancer Research
    Tristan Free · 2021 · BioTechniques
  99. Pretreatment Immune Status, Predicts Response to Definite Chemo Radiotherapy in Advanced Stages of Cervical Cancer Patients
    Swati Garg, Usha Shekhawat, Rajaat Vohra, Reshu Gupta · 2022 · The Journal of Obstetrics and Gynecology of India
  100. An update on novel multiple myeloma targets
    Massimo Offidani, Laura Corvatta, Sonia Morè, Valentina Maria Manieri, Attilio Olivieri · 2022 · Expert Review of Hematology